Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3325599988;99989;99990 chr2:178537444;178537443;178537442chr2:179402171;179402170;179402169
N2AB3161495065;95066;95067 chr2:178537444;178537443;178537442chr2:179402171;179402170;179402169
N2A3068792284;92285;92286 chr2:178537444;178537443;178537442chr2:179402171;179402170;179402169
N2B2419072793;72794;72795 chr2:178537444;178537443;178537442chr2:179402171;179402170;179402169
Novex-12431573168;73169;73170 chr2:178537444;178537443;178537442chr2:179402171;179402170;179402169
Novex-22438273369;73370;73371 chr2:178537444;178537443;178537442chr2:179402171;179402170;179402169
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTC
  • RefSeq wild type template codon: CAG
  • Domain: Ig-157
  • Domain position: 53
  • Structural Position: 139
  • Q(SASA): 0.1437
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/I rs1692136701 None 0.002 N 0.411 0.071 0.515259903717 gnomAD-4.0.0 7.96536E-06 None None None None N None 0 0 None 0 2.77809E-05 None 0 0 0 0 1.21051E-04

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.4983 ambiguous 0.467 ambiguous -2.065 Highly Destabilizing 0.013 N 0.312 neutral N 0.516223222 None None N
V/C 0.915 likely_pathogenic 0.9062 pathogenic -1.521 Destabilizing 0.998 D 0.667 neutral None None None None N
V/D 0.8766 likely_pathogenic 0.8586 pathogenic -2.561 Highly Destabilizing 0.973 D 0.717 prob.delet. N 0.48918873 None None N
V/E 0.7332 likely_pathogenic 0.6783 pathogenic -2.483 Highly Destabilizing 0.887 D 0.662 neutral None None None None N
V/F 0.4089 ambiguous 0.3964 ambiguous -1.398 Destabilizing 0.965 D 0.661 neutral N 0.49781082 None None N
V/G 0.6846 likely_pathogenic 0.6993 pathogenic -2.464 Highly Destabilizing 0.876 D 0.657 neutral D 0.528133727 None None N
V/H 0.8959 likely_pathogenic 0.8696 pathogenic -2.03 Highly Destabilizing 0.998 D 0.741 deleterious None None None None N
V/I 0.0997 likely_benign 0.0983 benign -1.007 Destabilizing 0.002 N 0.411 neutral N 0.464620966 None None N
V/K 0.8409 likely_pathogenic 0.7918 pathogenic -1.79 Destabilizing 0.945 D 0.663 neutral None None None None N
V/L 0.3734 ambiguous 0.3387 benign -1.007 Destabilizing 0.045 N 0.53 neutral N 0.478878343 None None N
V/M 0.3484 ambiguous 0.3265 benign -0.853 Destabilizing 0.963 D 0.588 neutral None None None None N
V/N 0.7447 likely_pathogenic 0.738 pathogenic -1.765 Destabilizing 0.717 D 0.717 prob.delet. None None None None N
V/P 0.9905 likely_pathogenic 0.9914 pathogenic -1.33 Destabilizing 0.837 D 0.693 prob.neutral None None None None N
V/Q 0.7105 likely_pathogenic 0.6638 pathogenic -1.855 Destabilizing 0.961 D 0.711 prob.delet. None None None None N
V/R 0.787 likely_pathogenic 0.7251 pathogenic -1.3 Destabilizing 0.973 D 0.741 deleterious None None None None N
V/S 0.5875 likely_pathogenic 0.5884 pathogenic -2.289 Highly Destabilizing 0.148 N 0.5 neutral None None None None N
V/T 0.494 ambiguous 0.4623 ambiguous -2.105 Highly Destabilizing 0.531 D 0.519 neutral None None None None N
V/W 0.9645 likely_pathogenic 0.9582 pathogenic -1.742 Destabilizing 1.0 D 0.725 prob.delet. None None None None N
V/Y 0.8604 likely_pathogenic 0.8395 pathogenic -1.473 Destabilizing 0.987 D 0.675 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.